Comparison between pre-exercise casein peptide and intact casein supplementation on glucose tolerance in mice fed a high-fat diet

Appl Physiol Nutr Metab. 2018 Apr;43(4):355-362. doi: 10.1139/apnm-2017-0485. Epub 2017 Nov 1.

Abstract

We hypothesized that along with exercise, casein peptide supplementation would have a higher impact on improving glucose tolerance than intact casein. Male 6-week-old ICR mice were provided a high-fat diet to induce obesity and glucose intolerance. The mice were randomly divided into 4 treatment groups: control (Con), endurance training (Tr), endurance training with intact casein supplementation (Cas+Tr), and endurance training with casein peptide supplementation (CP+Tr). The mice in each group were orally administrated water, intact casein, or casein peptide (1.0 mg/g body weight, every day), and then subjected to endurance training (15-25 m/min, 60 min, 5 times/week for 4 weeks) on a motor-driven treadmill 30 min after ingestion. Our results revealed that total intra-abdominal fat was significantly lower in CP+Tr than in Con (p < 0.05). Following an oral glucose tolerance test, the blood glucose area under the curve (AUC) was found to be significantly smaller for CP+Tr than for Con (p < 0.05). Moreover, in the soleus muscle, glucose transporter 4 (GLUT4) protein levels were significantly higher in CP+Tr than in Con (p < 0.01). However, intra-abdominal fat, blood glucose AUC, and GLUT4 protein content in the soleus muscle did not alter in Tr and Cas+Tr when compared with Con. These observations suggest that pre-exercise casein peptide supplementation has a higher effect on improving glucose tolerance than intact casein does in mice fed a high-fat diet.

Keywords: GLUT4; casein peptide; caséine intacte; endurance training; entraînement en endurance; glucose tolerance; intact casein; peptide de caséine; tolérance au glucose.

Publication types

  • Comparative Study

MeSH terms

  • Adiposity
  • Animals
  • Biomarkers / blood
  • Blood Glucose / metabolism*
  • Caseins / administration & dosage*
  • Diet, High-Fat*
  • Dietary Supplements*
  • Disease Models, Animal
  • Energy Intake
  • Glucose Intolerance / blood
  • Glucose Intolerance / diet therapy*
  • Glucose Intolerance / etiology
  • Glucose Intolerance / physiopathology
  • Glucose Transporter Type 4 / metabolism
  • Intra-Abdominal Fat / metabolism
  • Intra-Abdominal Fat / physiopathology
  • Male
  • Mice, Inbred ICR
  • Muscle, Skeletal / metabolism
  • Obesity / blood
  • Obesity / physiopathology
  • Peptide Fragments / administration & dosage*
  • Time Factors
  • Weight Gain

Substances

  • Biomarkers
  • Blood Glucose
  • Caseins
  • Glucose Transporter Type 4
  • Peptide Fragments
  • Slc2a4 protein, mouse